{
}
UBS forecasts a decline in the Canadian dollar due to ongoing economic challenges, including recession risks and disappointing labor market data. The USDCAD exchange rate is expected to rise to between 1.44 and 1.46, influenced by tariffs, as inflation remains high and the Bank of Canada faces limited rate cuts. This environment of stagflation could significantly impact trade and investment decisions globally.
Lululemon's price target has been reduced to $335 from $376 by UBS. This adjustment reflects the latest analysis and market conditions impacting the company's valuation.
Morgan Stanley has lowered its price target for Lululemon to $373 from $411. This adjustment reflects a shift in market expectations for the athletic apparel company.
Wells Fargo has lowered its price target on lululemon athletica to $315 from $375 while maintaining an equalweight rating. The company, known for its technical sportswear, generates 45.9% of net sales from directly operated stores, 44.8% from online sales, and 9.3% from other sources, with a significant presence in the U.S. (66% of sales).
Deutsche Bank has lowered its price target on lululemon athletica to $362 from $401 while maintaining a hold rating. The company specializes in technical sportswear, with net sales primarily generated from directly operated stores (45.9%) and online sales (44.8%). Geographically, 66% of sales come from the United States, followed by Canada (13.4%), China (10%), and other regions (10.6%).
Goldman Sachs has lowered its price target for lululemon athletica Inc. to $363 from $397 while maintaining a neutral rating. The company, known for its technical sportswear, generates 45.9% of its net sales from directly operated stores, 44.8% from online sales, and 9.3% from other sources. Geographically, 66% of sales come from the United States, followed by Canada (13.4%), China (10%), and other regions (10.6%).
Citigroup's stock has risen over 22% in the past six months, but its 3% dividend yield and high valuation ratios suggest caution for investors. In contrast, Toronto-Dominion Bank, despite facing regulatory challenges in the U.S. and an asset cap, offers a more attractive 4.8% dividend yield and remains financially strong, with growth potential in its Canadian operations.
UBS analyst Esther Rajavelu has maintained a Neutral rating on Ionis Pharmaceuticals with a price target of $45, as the stock trades near its 52-week low at $31.40. The company is focused on launching Tryngolza for familial chylomicronemia syndrome and has partnered with Sobi for commercialization outside the U.S. Despite a revenue decline of 10.5% to $705 million, Ionis has secured EU approval for WAINZUA and is advancing its investigational treatments, while management anticipates Phase 3 data for olezarsen in severe hypertriglyceridemia by late 2025.
Charles Schwab Investment Management Inc. reduced its holdings in Enerflex Ltd. by 10.3%, owning 322,320 shares valued at approximately $3.2 million. Despite a current Buy rating, top analysts recommend five other stocks as better investment options. Enerflex's recent quarterly dividend was $0.026 per share, yielding 1.36%.
At the 2024 World Pork Expo, Rabobank's Christine McCracken highlighted a positive shift in the North American pork market, with improved supply-demand balance and reduced feed costs boosting profitability for U.S. hog producers. Despite softer pork demand, particularly in the U.S., there are optimistic signs for the second half of the year, especially with reduced competition from beef and chicken. Canada and Mexico remain vital partners, with Mexico's strong demand for U.S. pork driven by cultural preferences and economic growth, despite potential uncertainties from political changes.
CAN
Country
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Canadian dollar faces decline amid economic challenges and recession risks
11:56 28.03.2025
Lululemon price target reduced to 335 by UBS analysts
11:45 28.03.2025
Lululemon price target reduced by Morgan Stanley to 373 from 411
11:31 28.03.2025
wells fargo lowers lululemon price target to 315 maintains equalweight rating
10:53 28.03.2025
Deutsche Bank lowers lululemon price target while maintaining hold rating
10:53 28.03.2025
goldman sachs lowers lululemon price target while maintaining neutral rating
10:51 28.03.2025
undervalued bank stock offers high yield despite regulatory challenges
09:35 28.03.2025
Ionis Pharmaceuticals maintains focus on Tryngolza launch amid mixed analyst ratings
09:11 28.03.2025
enerflex stock performance and recent institutional investment changes
08:21 28.03.2025
North American pork market outlook shows signs of recovery and demand shifts
Mexican Peso
United States Dollar
MEX
CAN
USA
Christine Mccracken
Lee Williamson
Sarah Mikesell
Show more
01:59 28.03.2025
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Banking Regulations
Finance Mergers & Acquisitions
Global Financial Events
Retail and Consumer Goods
Central Bank Actions
GDP Growth & Recession Forecasts
CEO Changes
Global Trade Developments
Industry Mergers & Acquisitions
Financial Scams and Security
Market Analysis and Predictions
Inflation and Monetary Impact
Government Policies
Government Economic Policies
Supply Chain Management
Domestic Politics
Workplace Trends
Countries:
Companies:
The Goldman Sachs Group, Inc.
JPMorgan Chase & Co.
Tesla, Inc.
Apple Inc.
Bank of America Corporation
Barclays PLC
Wells Fargo & Company
Citigroup Inc.
Deutsche Bank Money Market PP
Morgan Stanley
Huawei Technologies CO. Ltd.
Lloyds Banking Group plc
Credit Suisse Strategic Income I
AXA SA
Safran SA
Banco Santander, S.A.
Novartis AG
Swiss Re AG
Beazley plc
UBS AG
Currencies:
United States Dollar
Euro
Chinese Yuan
British Pound Sterling
Swiss Franc
Japanese Yen
Indian Rupee
Russian Ruble
Canadian Dollar
Australian Dollar
United Arab Emirates Dirham
Saudi Riyal
Danish Krone
Offshore Chinese Yuan
Hong Kong Dollar
Mexican Peso
Indonesian Rupiah
South Korean Won
Malaysian Ringgit
Vietnamese Đồng
People: